IQVIA HOLDINGS INC (IQV) Stock Price & Overview

NYSE:IQVUS46266C1053

Current stock price

170.72 USD
-2.54 (-1.47%)
At close:
170.72 USD
0 (0%)
After Hours:

The current stock price of IQV is 170.72 USD. Today IQV is down by -1.47%. In the past month the price decreased by -2.16%. In the past year, price increased by 17.29%.

IQV Key Statistics

52-Week Range134.645 - 247.045
Current IQV stock price positioned within its 52-week range.
1-Month Range162.22 - 180.24
Current IQV stock price positioned within its 1-month range.
Market Cap
28.659B
P/E
14.31
Fwd P/E
13.32
EPS (TTM)
11.93
Dividend Yield
N/A

IQV Stock Performance

Today
-1.47%
1 Week
+4.19%
1 Month
-2.16%
3 Months
-29.57%
Longer-term
6 Months -13.85%
1 Year +17.29%
2 Years -26.34%
3 Years -9.30%
5 Years -27.26%
10 Years N/A

IQV Stock Chart

IQVIA HOLDINGS INC / IQV Daily stock chart

IQV Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to IQV. When comparing the yearly performance of all stocks, IQV is a bad performer in the overall market: 76.26% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

IQV Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to IQV. While IQV has a great profitability rating, there are quite some concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IQV Earnings

On February 5, 2026 IQV reported an EPS of 3.42 and a revenue of 4.36B. The company missed EPS expectations (-0.33% surprise) and beat revenue expectations (1.91% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 5, 2026
PeriodQ4 / 2025
EPS Reported$3.42
Revenue Reported4.364B
EPS Surprise -0.33%
Revenue Surprise 1.91%

IQV Forecast & Estimates

31 analysts have analysed IQV and the average price target is 243.06 USD. This implies a price increase of 42.38% is expected in the next year compared to the current price of 170.72.

For the next year, analysts expect an EPS growth of 7.43% and a revenue growth 6.51% for IQV


Analysts
Analysts83.87
Price Target243.06 (42.37%)
EPS Next Y7.43%
Revenue Next Year6.51%

IQV Groups

Sector & Classification

IQV Financial Highlights

Over the last trailing twelve months IQV reported a non-GAAP Earnings per Share(EPS) of 11.93. The EPS increased by 7.09% compared to the year before.


Income Statements
Revenue(TTM)16.31B
Net Income(TTM)1.36B
Industry RankSector Rank
PM (TTM) 8.34%
ROA 4.54%
ROE 20.91%
Debt/Equity 2.14
Chartmill High Growth Momentum
EPS Q2Q%9.62%
Sales Q2Q%10.26%
EPS 1Y (TTM)7.09%
Revenue 1Y (TTM)5.87%

IQV Ownership

Ownership
Inst Owners102.12%
Shares167.87M
Float166.02M
Ins Owners0.94%
Short Float %2.54%
Short Ratio1.85

About IQV

Company Profile

IQV logo image IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

Company Info

IPO: 2013-05-09

IQVIA HOLDINGS INC

2400 Ellis Road

Durham NORTH CAROLINA 27703 US

CEO: Ari Bousbib

Employees: 93000

IQV Company Website

IQV Investor Relations

Phone: 19199982000

IQVIA HOLDINGS INC / IQV FAQ

Can you describe the business of IQVIA HOLDINGS INC?

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.


Can you provide the latest stock price for IQVIA HOLDINGS INC?

The current stock price of IQV is 170.72 USD. The price decreased by -1.47% in the last trading session.


Does IQV stock pay dividends?

IQV does not pay a dividend.


How is the ChartMill rating for IQVIA HOLDINGS INC?

IQV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


On which exchange is IQV stock listed?

IQV stock is listed on the New York Stock Exchange exchange.


What is the next earnings date for IQV stock?

IQVIA HOLDINGS INC (IQV) will report earnings on 2026-05-04, before the market open.


Who owns IQVIA HOLDINGS INC?

You can find the ownership structure of IQVIA HOLDINGS INC (IQV) on the Ownership tab.